IMCC Financial Statements From 2010 to 2026

IMCC Stock  USD 1.49  0.10  7.19%   
Im Cannabis' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Im Cannabis' valuation are provided below:
Im Cannabis Corp does not right now have any fundamental measures for analysis.
Check Im Cannabis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Im Cannabis' main balance sheet or income statement drivers, such as , as well as many indicators such as . IMCC financial statements analysis is a perfect complement when working with Im Cannabis Valuation or Volatility modules.
Check out the analysis of Im Cannabis Correlation against competitors.

Im Cannabis Corp Company Profit Margin Analysis

Im Cannabis' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Profit Margin

 = 

Net Income

Revenue

X

100

More About Profit Margin | All Equity Analysis

Current Im Cannabis Profit Margin

    
  (0.09) %  
Most of Im Cannabis' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Im Cannabis Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition

Based on the latest financial disclosure, Im Cannabis Corp has a Profit Margin of -0.0897%. This is 99.2% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The profit margin for all United States stocks is 92.94% lower than that of the firm.

Im Cannabis Corp Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Im Cannabis's current stock value. Our valuation model uses many indicators to compare Im Cannabis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Im Cannabis competition to find correlations between indicators driving Im Cannabis's intrinsic value. More Info.
Im Cannabis Corp is rated third overall in return on equity category among its peers. It is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Im Cannabis' earnings, one of the primary drivers of an investment's value.

About Im Cannabis Financial Statements

Im Cannabis stakeholders use historical fundamental indicators, such as Im Cannabis' revenue or net income, to determine how well the company is positioned to perform in the future. Although Im Cannabis investors may analyze each financial statement separately, they are all interrelated. For example, changes in Im Cannabis' assets and liabilities are reflected in the revenues and expenses on Im Cannabis' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Im Cannabis Corp. Please read more on our technical analysis and fundamental analysis pages.
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. The company serves medical patients and adult-use recreational consumers. IM Cannabis is traded on NASDAQ Exchange in the United States.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Im Cannabis Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Im Cannabis' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Im Cannabis Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Im Cannabis Corp Stock:
Check out the analysis of Im Cannabis Correlation against competitors.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Im Cannabis. If investors know IMCC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Im Cannabis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Im Cannabis Corp is measured differently than its book value, which is the value of IMCC that is recorded on the company's balance sheet. Investors also form their own opinion of Im Cannabis' value that differs from its market value or its book value, called intrinsic value, which is Im Cannabis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Im Cannabis' market value can be influenced by many factors that don't directly affect Im Cannabis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Im Cannabis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Im Cannabis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Im Cannabis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.